SANGAMO THERAPEUTICS, INC. Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-17.
Financial Statements › Notes
us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff · last filed 2025-03-17
- SANGAMO THERAPEUTICS, INC. debt securities, available-for-sale, allowance for credit loss, writeoff for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- SANGAMO THERAPEUTICS, INC. debt securities, available-for-sale, allowance for credit loss, writeoff for fiscal 2023 was $400.00K.
| Period end | Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-17 |
| 2023-12-31 | $400.00K 10-K · filed 2025-03-17 |